Find and Pitch Jounalists, Get Your Story Covered

Tags: myelofibrosis inpatient to outpatient transitions medication reconciliation inpatient care outpatient care

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Scotland first in UK to approve new myeloma treatment - 8 days ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 3 months ago
2	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma - 29 days ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - about 2 months ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - about 2 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 3 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 6 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - 11 months ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 3 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 9 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 9 months ago High NfL Levels Predict Greater MS Disability Within 2 Years - 10 months ago Emerging Biomarkers of Multiple Sclerosis in Blood and CSF - 11 months ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 6 months ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - 9 months ago AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy - 9 months ago Prenatal Folate May Program Hematopoietic Stem Cell Function Into Adulthood - 9 months ago
6	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	FDA Panel Endorses Imetelstat for MDS-Related Anemia - 6 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 6 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 8 months ago Ruxolitinib Combinations Reduce Spleen Volume in Myelofibrosis - 9 months ago Lovo-Cel 'Life-Changing, Transformative' in Sickle Cell Disease - 9 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 10 months ago
7	Isabella Cueto STAT News Journalist on chronic disease. healthjournalism	NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease - 7 months ago
8	Pharmacy Times Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Challenges in Outpatient Transition For Myelofibrosis Care - 8 months ago Inpatient to Outpatient: Myelofibrosis Care - 8 months ago Challenges in Myelofibrosis: Red Blood Cell Transfusion Shortages - 9 months ago Blood Shortages Impacting Myelofibrosis Care - 9 months ago
9	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	Novartis Announces Positive Findings for Scemblix in Newly Diagnosed Chronic Myeloid Leukemia - 9 months ago
10	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear - 9 months ago

Journalists covering myelofibrosis